Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior lapse-in-funding notice (Revision: v3.4.1). These appear to be maintenance/status updates rather than changes to the study details.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added and the revision tag updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI/text updates include adding a 'Show glossary' toggle, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision label updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section added with Massachusetts as a location, replacing the old Massachusetts Locations entry. HHS Vulnerability Disclosure removed and page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.